Outsourced Pharma App Notes & Case Studies

1. Understanding Technology Transfer In Pharmaceutical Contract Manufacturing 10/16/2024

   Technology transfer is a crucial process in the pharmaceutical industry, ensuring drugs developed in labs can be manufactured consistently at scale.

2. Partnering With Health Systems: Essential Tips For CGT Commercialization 12/5/2025

   Successful cell and gene therapy commercialization requires early, detailed manufacturer collaboration with health systems to ensure scalable operations and seamless patient access beyond the clinical trial.

3. Selecting A Platform Filter For High Concentration mAbs 4/9/2025

   Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.

4. Secondary Packaging: Labeling, Cartoning, Clamshell, And Stretch Carding 6/23/2026

   Tight timelines and coordinated packaging execution drove a high-stakes product launch ahead of a national competitor, ultimately capturing over half the market and setting a new benchmark.

5. Advantages Of Spray-Dried Mannitol In Roll Compaction 4/2/2025

   Pharmaceutical excipients like mannitol enhance formulation stability, flowability, and compressibility, which are crucial for robust tablets. Read how these properties improve patient compliance.

6. Producing Quality APIs At Scale 5/7/2026

   Targeted process optimization transformed an early‑phase API with yield and impurity challenges into a scalable, high‑quality manufacturing process ready to support ongoing drug development.

7. 3D Screen Printing: Enabling A New Generation Of Complex Formulations 3/17/2025

   Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

8. Benchmarking Filtration Performance Of TFF Cassettes 5/30/2025

   Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.

9. From Plasmids To Cell-Free DNA For Advanced Gene Therapies 6/25/2026

   Switching from bacterial plasmids to cell-free circular ssDNA boosts gene-editing safety and precision, reduces toxicity, enables up to 75% knock-in efficiency, and improves primary cell viability.

10. Generation Of A Contamination Control Strategy 8/16/2025

    An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.